|
TRIP13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.602400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.217800E-01 |
| Normal-vs-Stage2 |
1.107420E-01 |
| Normal-vs-Stage3 |
1.919580E-01 |
| Normal-vs-Stage4 |
2.038000E-01 |
| Stage1-vs-Stage2 |
9.019300E-04 |
| Stage1-vs-Stage3 |
3.408200E-01 |
| Stage1-vs-Stage4 |
3.531600E-01 |
| Stage2-vs-Stage3 |
3.558900E-04 |
| Stage2-vs-Stage4 |
8.824700E-03 |
| Stage3-vs-Stage4 |
7.108800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.837770E-01 |
| Normal-vs-AfricanAmerican |
7.182400E-01 |
| Normal-vs-Asian |
4.041400E-01 |
| Caucasian-vs-AfricanAmerican |
6.851500E-02 |
| Caucasian-vs-Asian |
7.029200E-01 |
| AfricanAmerican-vs-Asian |
2.230600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.351000E-01 |
| Normal-vs-Female |
3.887600E-01 |
| Male-vs-Female |
9.645600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.807240E-01 |
| Normal-vs-Age(41-60Yrs) |
7.408800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.522200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.601700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.203060E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.139000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.132790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.501420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.806100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.438500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.531600E-02 |
| Classical-VS-Follicular |
1.43780543027106E-11 |
| Classical-VS-Other |
3.517000E-01 |
| Classical-VS-Normal |
1.076830E-01 |
| Tall-VS-Follicular |
7.54270000000723E-05 |
| Tall-VS-Other |
1.151220E-01 |
| Tall-VS-Normal |
2.026100E-02 |
| Follicular-VS-Other |
2.540200E-01 |
| Follicular-VS-Normal |
3.923600E-02 |
| Other-VS-Normal |
8.263600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.314400E-01 |
| Normal-vs-N1 |
1.469640E-01 |
| N0-vs-N1 |
5.626500E-02 |
|
|
